Professor, Department of Life Sciences, Health, and Health Care Professions, School of Medicine and Surgery, Link Campus University, Rome, Italy,Italy
Dr. Luca Roncati is a highly accomplished researcher whose career is marked by pioneering studies in multiple areas of pathology and oncology. His work on gynecologic oncology, nanopathology, and COVID-19 has had a significant impact on medical science, particularly in improving diagnostic techniques and therapeutic options for patients. He has demonstrated leadership not only through his research but also in his educational roles and editorial leadership in major scientific journals. His innovative contributions to cancer treatment, as seen in his patents and research, position him as a key figure in medical advancement. The Roncati-Manenti Triad and his description of T rex lymphoma further illustrate his ability to make groundbreaking discoveries in pathology. Additionally, his COVID-19 research was instrumental during the pandemic and continues to influence the medical community today.
Professional Profile
Education🎓
Dr. Luca Roncati holds an extensive academic background in medicine and pathology. He graduated in Medicine and Surgery, followed by specialization in Pathological Anatomy, Oncology, Senology, Clinical Pathology, and Forensic Medicine. He has also achieved National Scientific Habilitation for roles in Obstetrical-Gynecological Sciences and Technical Sciences of Laboratory Medicine, solidifying his expertise in clinical, organizational, epidemiological, and social aspects of healthcare. Dr. Roncati’s qualifications have been recognized on an international level, particularly within the academic and healthcare sectors.
Professional Experience📝
Dr. Roncati is currently a Full-Time Professor of Pathology at Link Campus University in Rome, Italy, where he imparts knowledge in the fields of medical pathology and oncology. In addition, he holds a position as a Medical Executive at the University Hospital of Modena, where he works with interdisciplinary teams to deliver clinical care. He is also an Adjunct Professor at the University of Modena and Reggio Emilia. Throughout his career, he has served as an academic editor and reviewer for several prestigious journals, contributing to advancing knowledge in the fields of Oncology, Pathology, and Gynecology.
Research Interest🔎
Senology and Gynecologic Oncology: He is known for his in-depth research into the pathophysiology of breast cancer and gynecological malignancies.Pediatric Pathology: His work in pediatric oncology has provided critical insights into childhood cancers.Hematopathology and Soft Tissue Tumors: Dr. Roncati has contributed significantly to understanding hematologic conditions and soft tissue tumors.Nanopathology: He is recognized as a leading researcher in nanopathology, particularly in the integration of nanotechnology in medical diagnostics and treatment.COVID-19: Dr. Roncati was among the pioneering researchers investigating the impacts and pathology of COVID-19, publishing influential papers that have shaped the understanding of the disease.Forensic Pathology: As a forensic expert, he has contributed to advancements in medico-legal investigations.
Awards and Recognition🏆
International Research Recognition: His pioneering work in COVID-19 research and nanopathology has been widely cited. Academic Excellence: He has been selected as a distinguished academic by Times Higher Education and has been recognized for his contributions to the world university rankings. Innovative Cancer Research: He holds patents for anti-cancer therapies, cementing his place as a leader in cancer research.
Skills and Expertise🔬
Medical Research: Extensive experience in clinical and laboratory-based research, particularly in oncology and pathology.Patent Innovation: He is an inventor of anti-cancer therapies and holds international patents.Forensic Pathology: Expertise in medico-legal investigations, including autopsies and criminal pathology.Academic Leadership: Dr. Roncati has played a pivotal role in mentoring the next generation of pathologists and scientists.Nanotechnology in Medicine: Pioneering work in the application of nanotechnology to pathology and cancer research.
Conclusion💡
Dr. Luca Roncati exemplifies the qualities of a Best Researcher Award nominee. His extensive academic background, coupled with his pioneering research in oncology, nanopathology, and COVID-19, makes him a standout candidate. His innovation in anti-cancer therapies, along with his dedication to advancing scientific knowledge, demonstrates his remarkable ability to improve both patient care and medical practice. While there are areas for potential improvement, such as increased public engagement and cross-disciplinary collaboration, his current body of work is substantial and continues to shape the landscape of modern medicine. Dr. Roncati’s leadership, influence, and groundbreaking discoveries solidify his status as one of the leading medical researchers of our time. He is undoubtedly a deserving candidate for the Best Researcher Award.
Publications Top Noted✍
1. Title: Adjuvant Metronomic Chemotherapy After Surgery in pT1-T2 N0 M0 HER2-Positive and ER/PR-Positive Breast Cancer Plus Targeted Therapy, Anti-Hormonal Therapy, and Radiotherapy, with or Without Immunotherapy: A New Operational Proposal
2. Title: Ozone–Oxygen Therapy to Prevent HPV-Related Cancers of the Lower Gynecological Tract in Infected Patients: The Rationale for Further Developments
3. Title: COVID-19 and upper limb compression neuropathies: a review
-
Authors: Marra, Caterina; de Maria, Federico; Boccaletti, Martina; Roncati, Luca; Adani, Roberto
Year: Not specified
Citations: 0
4. Title: Ultramicronized Palmitoylethanolamide and Luteolin: Drug Candidates in Post-COVID-19 Critical Illness Neuropathy and Positioning-Related Peripheral Nerve Injury of the Upper Extremity
-
Authors: Roncati, Luca; Marra, Caterina; Gravina, Davide; Della Rosa, Norman; Adani, Roberto
Journal: Journal of Hand and Microsurgery
Year: 2024
Citations: 3
5. Title: A Real-World Nationwide Study on COVID-19 Trend in Italy during the Autumn–Winter Season of 2020 and 2021 Integrated with a Retrospective Analysis of the Mortality Burden per Year
-
Authors: Manenti, Antonio; Roncati, Luca; Sorrentino, Lorena; Gelmini, Roberta; Coppi, Francesca
Journal: Vascular
Year: 2024
Citations: 0
6. Title: Thoracic aortic pseudoaneurysm: Inside its pathophysiology
-
Authors: Manenti, Antonio; Roncati, Luca; Sorrentino, Lorena; Gelmini, Roberta; Coppi, Francesca
Journal: Vascular
Year: 2024
Citations: 0
7. Title: Editorial: Endocrine disruptors and diseases of brain and mind: past and prelude
8. Title: Reply to: Letter on the Recent Paper “Vascular ‘Long COVID’: A New Vessel Disease?”
9. Title: Vascular “Long COVID”: A New Vessel Disease?
-
Authors: Zanini, Giada; Selleri, Valentina; Roncati, Luca; Pinti, Marcello; Mattioli, Anna Vittoria
Year: Not specified
Citations: 37
10. Title: Trends in the COVID-19 Pandemic in Italy during the Summers of 2020, 2021 and 2022: A Real-World Nationwide Study
-
Authors: Roncati, Luca; Bartolacelli, Giulia; Galeazzi, Carlo; Caramaschi, Stefania
Journal: Pathogens
Year: 2023
Citations: 3
